X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (22148) 22148
Publication (1736) 1736
Book Review (365) 365
Book Chapter (158) 158
Book / eBook (118) 118
Dissertation (53) 53
Magazine Article (47) 47
Conference Proceeding (32) 32
Government Document (13) 13
Web Resource (6) 6
Journal / eJournal (5) 5
Trade Publication Article (4) 4
Presentation (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (18901) 18901
female (12352) 12352
antineoplastic agents, hormonal - therapeutic use (10021) 10021
index medicus (7760) 7760
oncology (7319) 7319
male (7290) 7290
middle aged (7215) 7215
aged (6125) 6125
breast neoplasms - drug therapy (5878) 5878
adult (5047) 5047
breast cancer (4069) 4069
treatment outcome (3623) 3623
cancer (3504) 3504
tamoxifen (3316) 3316
prostatic neoplasms - drug therapy (3238) 3238
tamoxifen - therapeutic use (3224) 3224
prostate cancer (2827) 2827
antineoplastic agents, hormonal - adverse effects (2812) 2812
antineoplastic agents, hormonal - administration & dosage (2631) 2631
breast neoplasms - pathology (2502) 2502
aged, 80 and over (2485) 2485
care and treatment (2358) 2358
chemotherapy, adjuvant (2261) 2261
antineoplastic agents, hormonal - pharmacology (2112) 2112
postmenopausal women (2097) 2097
therapy (2057) 2057
risk factors (2037) 2037
animals (1931) 1931
women (1920) 1920
chemotherapy (1914) 1914
prostatic neoplasms - pathology (1902) 1902
prognosis (1901) 1901
urology & nephrology (1796) 1796
obstetrics & gynecology (1755) 1755
carcinoma (1726) 1726
androgen antagonists - therapeutic use (1687) 1687
health aspects (1682) 1682
estrogen (1671) 1671
antineoplastic combined chemotherapy protocols - therapeutic use (1654) 1654
neoplasm staging (1583) 1583
hormonal therapy (1572) 1572
combined modality therapy (1563) 1563
research (1482) 1482
retrospective studies (1456) 1456
disease-free survival (1437) 1437
medicine & public health (1426) 1426
follow-up studies (1416) 1416
breast neoplasms - metabolism (1396) 1396
time factors (1370) 1370
hormonal-therapy (1368) 1368
endocrinology & metabolism (1308) 1308
radiotherapy (1287) 1287
risk (1232) 1232
endocrine therapy (1213) 1213
menopause (1203) 1203
postmenopause (1195) 1195
analysis (1185) 1185
prostate-specific antigen - blood (1165) 1165
survival (1148) 1148
expression (1137) 1137
tamoxifen - adverse effects (1126) 1126
surgery (1110) 1110
prostatic neoplasms - therapy (1064) 1064
survival analysis (1063) 1063
aromatase inhibitors (1054) 1054
medicine, general & internal (1044) 1044
prospective studies (1037) 1037
breast neoplasms - genetics (983) 983
drug resistance, neoplasm (974) 974
drug therapy (969) 969
radical prostatectomy (957) 957
randomized controlled trials as topic (955) 955
breast neoplasms - surgery (947) 947
survival rate (936) 936
tamoxifen - pharmacology (935) 935
breast neoplasms - mortality (927) 927
pharmacology & pharmacy (925) 925
quality of life (922) 922
receptors, estrogen - metabolism (917) 917
randomized-trial (908) 908
aromatase inhibitors - therapeutic use (904) 904
trial (881) 881
adolescent (878) 878
article (874) 874
prostatic neoplasms - radiotherapy (873) 873
tumors (871) 871
tamoxifen - administration & dosage (870) 870
disease progression (864) 864
neoplasms, hormone-dependent - drug therapy (863) 863
cell line, tumor (838) 838
pregnancy (830) 830
antineoplastic agents - therapeutic use (828) 828
metastasis (824) 824
prostatic neoplasms - mortality (820) 820
hematology, oncology and palliative medicine (808) 808
hormone replacement therapy (797) 797
hormones (795) 795
prostatic neoplasms - blood (782) 782
clinical trials as topic (779) 779
drug administration schedule (774) 774
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (66) 66
Collection Dvlpm't (Acquisitions) - Vendor file (9) 9
Collection Dvlpm't (Acquisitions) - Closed Orders (7) 7
Online Resources - Online (7) 7
UofT at Mississauga - Stacks (5) 5
UTL at Downsview - May be requested (4) 4
New College (Ivey) - Stacks (3) 3
St. Michael's Hospital - Stacks (3) 3
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (3) 3
Gerstein Science - Periodical Stacks (2) 2
Lakeridge Health Sciences - Oshawa (2) 2
UofT at Scarborough - Stacks (2) 2
Baycrest Hospital - Stacks (1) 1
Humber River Regional Hospital - Finch Stacks (1) 1
Mt Sinai Hospital - Online (1) 1
Robarts - Stacks (1) 1
Scarborough Hospital - General (1) 1
St Josephs Health Centre - Stacks (1) 1
Trinity College (John W Graham) - Stacks (1) 1
UofT at Scarborough - Withdrawn (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (19682) 19682
French (677) 677
German (479) 479
Japanese (424) 424
Spanish (307) 307
Russian (182) 182
Italian (153) 153
Polish (143) 143
Portuguese (114) 114
Chinese (85) 85
Czech (60) 60
Hungarian (60) 60
Dutch (30) 30
Danish (25) 25
Bulgarian (22) 22
Swedish (15) 15
Norwegian (14) 14
Finnish (12) 12
Korean (12) 12
Serbian (11) 11
Croatian (9) 9
Romanian (9) 9
Slovak (9) 9
Turkish (5) 5
Hebrew (4) 4
Ukrainian (4) 4
Slovenian (3) 3
Bosnian (2) 2
Afrikaans (1) 1
Estonian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2013, Volume 85, Issue 1, pp. 101 - 108
Purpose To assess the survival benefit of early vs late salvage hormonal therapy (HT), we performed a secondary analysis on patients who developed recurrence... 
Radiology | Hematology, Oncology and Palliative Medicine | PHASE-III TRIAL | ANDROGEN DEPRIVATION | RELAPSE | ONCOLOGY | DEFINITIVE RADIOTHERAPY | RANDOMIZED-TRIAL | ABLATION | RECURRENCE | SUPPRESSION | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | ANTIGEN | Neoplasm Recurrence, Local - radiotherapy | Prostatic Neoplasms - radiotherapy | Humans | Middle Aged | Neoplasm Recurrence, Local - drug therapy | Male | Neoplasm Recurrence, Local - mortality | Neoplasm Recurrence, Local - pathology | Time Factors | Antineoplastic Agents, Hormonal - therapeutic use | Prostatic Neoplasms - blood | Neoplasm Recurrence, Local - blood | Prostatic Neoplasms - drug therapy | Adenocarcinoma - radiotherapy | Salvage Therapy - mortality | Prostatic Neoplasms - pathology | Drug Administration Schedule | Adenocarcinoma - blood | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Prostate-Specific Antigen - blood | Prostatic Neoplasms - mortality | Analysis of Variance | Neoadjuvant Therapy - methods | Survival Analysis | Aged | Salvage Therapy - methods | Adenocarcinoma - mortality | Medical research | Cancer patients | Care and treatment | Nuclear radiation | Patient outcomes | Adjuvant treatment | Medicine, Experimental | Radiotherapy | Prostate cancer | Cancer | PROSTATE | MULTIVARIATE ANALYSIS | PATIENTS | HEALTH HAZARDS | FAILURES | METASTASES | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE | ANTIGENS | RADIOTHERAPY | HORMONES
Journal Article
Annals of Oncology, ISSN 0923-7534, 2015, Volume 26, Issue 8, pp. 1533 - 1546
The 14th St Gallen International Breast Cancer Conference (2015) reviewed substantial new evidence on locoregional and systemic therapies for early breast... 
Radiation therapy | Early breast cancer | St Gallen Consensus | Systemic adjuvant therapies | Surgery | early breast cancer | ADJUVANT CHEMOTHERAPY | ENDOCRINE THERAPY | PREMENOPAUSAL WOMEN | ESTROGEN-RECEPTOR | PATHOLOGICAL COMPLETE RESPONSE | TUMOR-INFILTRATING LYMPHOCYTES | OVARIAN-FUNCTION SUPPRESSION | NEOADJUVANT CHEMOTHERAPY | ONCOLOGY | radiation therapy | SENTINEL NODE | CONTRALATERAL PROPHYLACTIC MASTECTOMY | systemic adjuvant therapies | surgery | Carcinoma, Lobular - pathology | Receptors, Estrogen - metabolism | Humans | Carcinoma, Intraductal, Noninfiltrating - metabolism | Mastectomy - methods | Receptor, ErbB-2 - metabolism | Tamoxifen - administration & dosage | Breast Neoplasms - metabolism | Receptors, Progesterone - metabolism | Breast Neoplasms - therapy | Anthracyclines - administration & dosage | Carcinoma, Lobular - therapy | Carcinoma, Intraductal, Noninfiltrating - therapy | Antineoplastic Agents, Hormonal - therapeutic use | Axilla | Carcinoma, Ductal, Breast - pathology | Female | Carcinoma, Ductal, Breast - metabolism | Mastectomy, Segmental - methods | Trastuzumab - administration & dosage | Carcinoma, Ductal, Breast - therapy | Taxoids - administration & dosage | Carcinoma, Intraductal, Noninfiltrating - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Chemotherapy, Adjuvant - methods | Radiotherapy, Adjuvant - methods | Carcinoma, Lobular - metabolism | Platinum Compounds - administration & dosage | Lymph Node Excision - methods | Neoplasm Staging | Practice Guidelines as Topic | Special
Journal Article
2002, ISBN 9780824707118, 272
Provides how-to guidelines for inpatient and outpatient insulin therapy in children and adults and during pregnancy and in hyperglycemic emergencies.... 
drug therapy | Diabetes | Hormone therapy | Diabetes Mellitus | Insulin | Therapeutic use | Clinical & internal medicine | Endocrinology | Diabetes - Hormone therapy
eBook
BJU International, ISSN 1464-4096, 03/2014, Volume 113, Issue 2, pp. 7 - 12
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2011, Volume 365, Issue 2, pp. 107 - 118
A course of androgen-deprivation therapy before and during radiotherapy prolonged 10-year survival by about 7% among men with intermediate-risk prostate... 
MEDICINE, GENERAL & INTERNAL | EXTERNAL-BEAM RADIOTHERAPY | THERAPY ONCOLOGY GROUP | DOSE-ESCALATION TRIAL | FOLLOW-UP | RADICAL PROSTATECTOMY | RANDOMIZED CONTROLLED-TRIAL | SUPPRESSION | HORMONAL-THERAPY | GROUP RTOG | RADIATION-THERAPY | Multivariate Analysis | Prostatic Neoplasms - radiotherapy | Follow-Up Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Risk | Radiotherapy - adverse effects | Flutamide - adverse effects | Prostate - pathology | Leuprolide - administration & dosage | Aged, 80 and over | Gonadotropin-Releasing Hormone - therapeutic use | Goserelin - adverse effects | Gonadotropin-Releasing Hormone - agonists | Prostatic Neoplasms - drug therapy | Radiotherapy Dosage | Goserelin - administration & dosage | Prostatic Neoplasms - pathology | Survival Rate | Combined Modality Therapy | Erectile Dysfunction - etiology | Prostatic Neoplasms - mortality | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Androgen Antagonists - therapeutic use | Leuprolide - adverse effects | Aged | Flutamide - administration & dosage | Androgen Antagonists - adverse effects | Usage | Care and treatment | Hormone therapy | Diagnosis | Radiotherapy | Health aspects | Prostate cancer | Adenocarcinoma | Short term | Lymphatic system | Risk groups | Prostate-specific antigen | Mortality | Blood tests | Oncology | Metastasis | Radiation therapy | Phosphatase | Cancer therapies | Survival | Metastases | Androgens | Biopsy | Surgery | Prostate | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2004, Volume 58, Issue 5, pp. 1520 - 1529
Journal Article
European Urology, ISSN 0302-2838, 2016, Volume 71, Issue 4, pp. 630 - 642
Journal Article
2005, 1, ISBN 0520221516, 381
Testosterone has inspired dreams - of restored youth, recharged sexual appetites, faster running, quicker thinking, bigger muscles - since it was first... 
Testosterone | Family & Health | Hormone therapy | Sociology | Menopause | Rejuvenation | Longevity | Aphrodisiacs | Physiological effect | Therapeutic use | Hormone Replacement Therapy | trends | Doping in Sports
Book